Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Financiación no declarada

Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID

Slankamenac J, Ranisavljev M, Todorovic N, Ostojic J, Stajer V, Candow DG, Ratgeber L, Betlehem J, Acs P, Ostojic SM

Journal of nutritional science and vitaminology · 7 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2024-04-29 · J Nutr Sci Vitaminol (Tokyo) · vol. 70 · número 2 · págs. 174–178
Editorial
Center for Academic Publications Japan
Citado
16 citas · más que el 95% de estudios similares · 4.2× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
8 trabajos
Acceso
Acceso abierto (publicación gratuita)
Áreas de investigación
Long-Term Effects of COVID-19 · Fibromyalgia and Chronic Fatigue Syndrome Research · Exercise and Physiological Responses
Palabras clave
Creatine, Medicine, Placebo, Internal medicine, Analysis of variance, Randomized controlled trial, Creatine Monohydrate, Endocrinology
MeSH
brain, humans, fatigue, creatine, glucose, treatment outcome, double-blind method, dietary supplements, adult, middle aged, female, male, covid-19, sars-cov-2, post-acute covid-19 syndrome

10 autores

  • Jelena Slankamenac🇷🇸University of Novi Sad
  • Marijana Ranisavljev🇷🇸University of Novi Sad
  • Nikola Todorović🇷🇸University of Novi Sad
  • Jelena Nesovic Ostojic🇷🇸University of Novi Sad
  • Valdemar Štajer🇷🇸University of Novi Sad
  • Darren Glenn Candow🇨🇦University of Regina
  • László Rátgéber🇭🇺University of Pecs
  • József Betlehem🇭🇺University of Pecs
  • Pongrác Ács🇭🇺University of Pecs
  • Sergej M. Ostojić🇷🇸🇳🇴🇭🇺University of Novi Sad; University of Agder; University of Pecs

Resumen

El texto original del estudio, en el idioma en que se publicó.

Preliminary studies demonstrated beneficial effects of dietary creatine across different post-viral fatigue syndromes. Creatine is often co-administered with glucose to improve its potency yet whether glucose boost the efficacy of creatine in long COVID remains currently unknown. In this report, we investigate the effects of 8-wk creatine intake with and without glucose on patient-reported outcomes, exercise tolerance, and tissue creatine levels in patients with long COVID. Fifteen male and female long COVID adult patients (age 39.7±16.0 y; 9 women) with moderate fatigue and at least one of additional long COVID-related symptoms volunteered to participate in this randomized controlled parallel-group interventional trial. All patients were allocated in a double-blind parallel-group design (1 : 1 : 1) to receive creatine (8 g of creatine monohydrate per day), a mixture of creatine and glucose (8 g of creatine monohydrate and 3 g of glucose per day), or placebo (3 g of glucose per day) t.i.d. during an 8-wk intervention interval. Two-way ANOVA with repeated measures (treatment vs. time interaction) revealed significant differences in changes in total creatine levels between the groups, showing an interaction effect at two brain locations (right precentral white matter F=34.740, p=0.008; partial η2=0.72; left paracentral grey matter F=19.243, p=0.019; partial η2=0.88), with creatine and creatine-glucose outcompeted placebo to elevate creatine levels at these two locations. Several long COVID symptoms (including body aches, breathing problems, difficulties concentrating, headache, and general malaise) were significantly reduced in creatine-glucose group at 8-wk follow-up (p≤0.05); the effect sizes for reducing body aches, difficulties concentrating, and headache were 1.33, 0.80, and 1.12, respectively, suggesting a large effect of creatine-glucose mixture for these outcomes. Our preliminary findings suggest that supplying exogenous creatine with glucose could be recommended as an effective procedure in replenishing brain creatine pool and alleviating long COVID features in this prevalent condition.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.